the obvious reason: their big-spending pharmaceutical advertisers would drop them like hot potatoes.
.-related side effects. its manufacturer, eli lilly, plans to submit a new drug application to the fda in the second half of 2018.
.
.
as of this month, there are 56 companies in china involved in the commercialization of car cell therapies
.